Korean Circ J.  2021 May;51(5):452-454. 10.4070/kcj.2021.0022.

Endovascular Therapy of Iliac Artery Disease: Stent Matters

• Kim SH

• KMID: 2515771
• DOI: http://doi.org/10.4070/kcj.2021.0022

Reference

1. Rha SW, Choi SH, Kim DI, et al. Medical resource consumption and quality of life in peripheral arterial disease in Korea: PAD outcomes (PADO) research. Korean Circ J. 2018; 48:813–825. PMID: 30088358.

2. Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017; 69:e71–126. PMID: 27851992.

3. Aboyans V, Ricco JB, Bartelink ME, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018; 39:763–816. PMID: 28886620.

4. Soga Y, Iida O, Kawasaki D, et al. Contemporary outcomes after endovascular treatment for aorto-iliac artery disease. Circ J. 2012; 76:2697–2704. PMID: 22864278.

5. Krankenberg H, Zeller T, Ingwersen M, et al. Self-expanding versus balloon-expandable stents for iliac artery occlusive disease: the randomized ICE trial. JACC Cardiovasc Interv. 2017; 10:1694–1704. PMID: 28838480.

6. de Donato G, Bosiers M, Setacci F, et al. 24-Month data from the BRAVISSIMO: a large-scale prospective registry on iliac stenting for TASC A & B and TASC C & D lesions. Ann Vasc Surg. 2015; 29:738–750. PMID: 25733220.

7. Jang GY, Ha KS. Self-expandable stents in vascular stenosis of moderate to large-sized vessels in congenital heart disease: early and intermediate-term results. Korean Circ J. 2019; 49:932–942. PMID: 31190478.

8. Kim DY, Ko YG, Lee SJ, et al. Korean multicenter registry study of EPIC stents for the treatment of iliac artery disease: K-EPIC registry. Korean Circ J. 2021; 51:441–451.

9. Clair DG, Adams J, Reen B, et al. The EPIC nitinol stent system in the treatment of iliac artery lesions: one-year results from the ORION clinical trial. J Endovasc Ther. 2014; 21:213–222. PMID: 24754280.

10. Tsujimura T, Iida O, Fujita M, et al. Two-year clinical outcomes post implantation of Epic™ self-expanding nitinol stents for the aortoiliac occlusive disease in patients with peripheral arterial disease. J Atheroscler Thromb. 2018; 25:344–349. PMID: 28978866.